The clinical utility and epidemiological impact of self-testing for SARS-CoV-2 using antigen detecting diagnostics: a systematic review and meta-analysis

Lukas E. Brümmer, Christian Erdmann, Hannah Tolle, Sean McGrath, Ioana D. Olaru, Stephan Katzenschlager, Seda Yerlikaya, Maurizio Grilli, Nira R. Pollock, Berra Erkoşar, Aurélien Macé, Stefano Ongarello, Cheryl Johnson, Jilian A. Sacks, Claudia M. DenkingermedRxiv 2022 · DOI

This systematic review and meta-analysis evaluates the real-world impact of COVID-19 self-testing (C19ST) using rapid antigen tests. While the available data is currently limited to high-income countries and generally of low quality, the findings suggest that self-testing is a feasible, well-accepted tool that identifies cases missed by traditional testing and reduces societal burdens like quarantine duration.

What Problem Does This Paper Address?

Early in the pandemic, the mantra was "test, test, test." While gold-standard PCR tests are highly accurate, they are resource-intensive and often slow. Antigen-based rapid diagnostic tests (Ag-RDTs) offered a faster, cheaper alternative, but their effectiveness depends heavily on how they are implemented.

The core challenge is moving from "clinical accuracy" (how well the test works in a lab) to "clinical utility" (how much it actually helps people and public health). Specifically, the authors wanted to know: Does allowing people to test themselves at home actually help control the spread of SARS-CoV-2? Does it lead to better uptake, or does it just create confusion? This study was designed to provide the evidence base for the World Health Organization (WHO) to develop formal guidelines on self-testing.

Methods

The researchers conducted a systematic review and meta-analysis following PRISMA guidelines. They searched Medline and Web of Science for studies published between December 2020 and November 2021 that assessed the epidemiological impact and clinical utility of C19ST.

Key methodological features included:

  • Study Selection: Included any study with more than 100 participants that implemented C19ST and compared it to a "no testing" or "professional testing" scenario.
  • Quality Assessment: Used the Newcastle-Ottawa Scale (NOS) to evaluate the risk of bias and the GRADE approach to determine the certainty of the evidence.
  • Statistical Analysis: Employed a random-intercept logistic regression model to meta-analyze proportions like test positivity and uptake.

Datasets

The review synthesized data from 11 studies comprising 17 distinct datasets, representing over 1.1 million individuals.

  • Geographic Distribution: All studies were from high-income countries: United Kingdom (47%), Germany (23.5%), Austria (17.6%), and the Netherlands (11.8%).
  • Participants: The majority (nearly 70%) were school students and teachers, followed by the general population and healthcare staff.
  • Tests Used: Common kits included the Innova SARS-CoV-2 Rapid Antigen Self-Test and the SD Biosensor "Standard Q."

Key Insights and Ideas

  • Finding the "Invisible" Cases: Even with a low pooled positivity rate of 0.2%, these tests identified thousands of cases in populations that otherwise would not have been tested. This suggests C19ST acts as a safety net for catching asymptomatic spreaders.
  • The "Feel-Safe" Factor: Beyond the biology, there is a psychological benefit. Participants reported feeling safer attending in-person school or work when self-testing was available.
  • Operational Barriers Matter: Testing uptake varied wildly (from 25.8% to 75.7%). The authors noted that "friction" in the process—such as requiring users to download a specific smartphone app before testing—significantly lowered participation.
  • Societal "Side Effects": One of the most interesting findings was that C19ST reduced quarantine duration and work absenteeism. This highlights that the utility of a test isn't just about health outcomes, but about maintaining societal function.

Key Results

  • Test Positivity: The pooled positivity rate was 0.2% (95% CI 0.1% to 0.4%). While low, these were cases identified in settings where no other dedicated testing was occurring.
  • Uptake: In studies where testing was voluntary, the pooled uptake was 53.2% (95% CI 36.7% to 68.9%).
  • Reporting: When required by study design, result reporting was high (over 90%).
  • User Confidence: Participants generally favored self-testing and expressed high confidence in their ability to perform the swabbing and testing correctly.

Limitations and Future Work

The authors are candid about the "very low certainty" of the current evidence. The primary limitations include:

  1. Low Study Quality: The median quality score was only 3 out of 9 stars on the NOS scale, indicating a high risk of bias in the included observational studies.
  2. Geographic Bias: There is a total lack of data from low- and middle-income countries (LMICs). Implementation challenges and utility might look very different in resource-constrained settings.
  3. Transmission Uncertainty: While self-testing identifies cases, the actual impact on reducing virus transmission remains "uncertain" because few studies used a rigorous control group to measure secondary attack rates.

Future Work: The authors call for urgent research in LMICs and more robust studies to "disentangle" the impact of self-testing from other interventions like masking or professional testing.

Summary updated

Abstract

ABSTRACT Introduction Self-testing for COVID-19 (C19ST) based on antigen detecting diagnostics could significantly support controlling the SARS-CoV-2 pandemic. To inform the World Health Organization in developing a C19ST guideline, we performed a systematic review and meta-analysis of the available literature. Methods We electronically searched Medline and the Web of Science core collection, performed secondary reference screening, and contacted experts for further relevant publications. Any study published between December 1, 2020 and November 30, 2021 assessing the epidemiological impact and clinical utility of C19ST was included. Study quality was evaluated using the Newcastle Ottawa Scale (NOS). The review was registered on PROSPERO (CRD42022299977). Results 11 studies only from high-income countries with an overall low quality (median of 3/9 stars on the NOS) were found. Pooled C19ST positivity was 0.2% (95% CI 0.1% to 0.4%; eight data sets) in populations where otherwise no dedicated testing would have occurred. The impact of self-testing on virus transmission was uncertain. Positive test results mainly resulted in people having to isolate without further confirmation of results (eight data sets). When testing was voluntary by study design, pooled testing uptake was 53.2% (95% CI 36.7% to 68.9%; five data sets. Outside direct health impacts, C19ST reduced quarantine duration and absenteeism from work, and made study participants feel safer. Study participants favored self-testing and were confident that they performed testing and sampling correctly. Conclusions The present data suggests that C19ST could be a valuable tool in reducing the spread of COVID-19, as it can achieve good uptake, may identify additional cases, and was generally perceived as positive by study participants. However, data was very limited and heterogenous, and further research especially in low- and middle-income countries is needed to assess the clinical utility and epidemiological impact of C19ST in more detail. CONTRIBUTIONS TO THE LITERATURE - COVID-19 self-testing (C19ST) using antigen detection could conceivably support pandemic control. A current PubMed search found no systematic evidence synthesis of studies assessing the epidemiological impact and clinical utility of C19ST implementation - We systematically reviewed and meta-analyzed 11 studies including more than 1.1 million persons tested - C19ST can achieve good uptake, may identify additional cases, and was general perceived as positive by study participants, suggesting it to be a valuable tool in reducing the spread of SARS-CoV-2 - Further data especially from low- and middle-income countries is needed to understand the impact of C19ST in more detail
BibTeX
@misc{brummer2022clinical,
  author = {Lukas E. Brümmer and Christian Erdmann and Hannah Tolle and Sean McGrath and Ioana D. Olaru and Stephan Katzenschlager and Seda Yerlikaya and Maurizio Grilli and Nira R. Pollock and Berra Erkoşar and Aurélien Macé and Stefano Ongarello and Cheryl Johnson and Jilian A. Sacks and Claudia M. Denkinger},
  title = {{The clinical utility and epidemiological impact of self-testing for SARS-CoV-2 using antigen detecting diagnostics: a systematic review and meta-analysis}},
  year = {2022},
  doi = {10.1101/2022.07.03.22277183},
  howpublished = {medRxiv},
}
Figure